U, L., B, G., D, D. G., T, S. J., B, G., K, L. G., . . . LE, K. (2021). Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis. Rheumatology (Oxford, England), 60(8), 3635. https://doi.org/10.1093/rheumatology/keaa825
Chicago Style (17th ed.) CitationU, Lindström, et al. "Comparison of Treatment Retention and Response to Secukinumab Versus Tumour Necrosis Factor Inhibitors in Psoriatic Arthritis." Rheumatology (Oxford, England) 60, no. 8 (2021): 3635. https://doi.org/10.1093/rheumatology/keaa825.
MLA (9th ed.) CitationU, Lindström, et al. "Comparison of Treatment Retention and Response to Secukinumab Versus Tumour Necrosis Factor Inhibitors in Psoriatic Arthritis." Rheumatology (Oxford, England), vol. 60, no. 8, 2021, p. 3635, https://doi.org/10.1093/rheumatology/keaa825.